Fil LTD Insmed Inc Transaction History

Fil LTD

$103 Billion
Q3 2024

A detailed history of Fil LTD transactions in Insmed Inc stock. As of the latest transaction made, Fil LTD holds 2,439,748 shares of INSM stock, worth $180 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

2,439,748

Previous 1,518,114 60.71%

Holding current value

$180 Million

Previous $102 Million 75.1%

% of portfolio

0.17%

Previous 0.11%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$62.0 - $79.01 $57.1 Million - $72.8 Million	921,634 Added 60.71%	2,439,748 $178 Million
Q2 2024 Aug 13, 2024	BUY	$22.0 - $69.71 $17.6 Million - $55.6 Million	797,869 Added 110.78%	1,518,114 $102 Million
Q1 2024 May 13, 2024	BUY	$25.72 - $29.94 $741,096 - $862,691	28,814 Added 4.17%	720,245 $19.5 Million
Q4 2023 Feb 13, 2024	SELL	$23.42 - $31.74 $3.27 Million - $4.44 Million	-139,771 Reduced 16.82%	691,431 $21.4 Million
Q3 2023 Nov 13, 2023	BUY	$19.86 - $26.93 $9.43 Million - $12.8 Million	474,805 Added 133.22%	831,202 $21 Million
Q2 2023 Aug 11, 2023	SELL	$16.44 - $21.1 $1.37 Million - $1.75 Million	-83,126 Reduced 18.91%	356,397 $7.52 Million
Q1 2023 May 11, 2023	BUY	$16.26 - $21.73 $2.33 Million - $3.11 Million	143,313 Added 48.38%	439,523 $7.49 Million
Q4 2022 Feb 13, 2023	BUY	$16.98 - $23.15 $4.81 Million - $6.56 Million	283,487 Added 2228.15%	296,210 $5.92 Million
Q3 2022 Nov 10, 2022	BUY	$20.88 - $28.21 $265,656 - $358,915	12,723 New	12,723 $274,000

Others Institutions Holding INSM

# of Institutions

467

Shares Held

182M

Call Options Held

2.27M

Put Options Held

3.33M

View Full List

About INSMED Inc

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $10B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

More about INSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fil LTD, based on Form 13F filings with the SEC.

News

Stay updated on Fil LTD with notifications on news.

Account